Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03602144 · ClinicalTrials.gov registry record · NA

Breakfast and Muscle Health in Children

A NA study of Nutrition and Body Composition, sponsored by University of Arkansas, Fayetteville.

Completed
Registry status
NA
Development phase
88
Enrollment target
1
Study location

NCT03602144: Completed NA study of Nutrition and Body Composition, sponsored by University of Arkansas, Fayetteville.

NCT03602144 is a NA study of Nutrition and Body Composition that has completed, run by University of Arkansas, Fayetteville. The registered enrollment target is 88 participants, below the 3,205-participant average among 22 other Nutrition trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03602144, a NA study of Nutrition and Body Composition, has completed, sponsored by University of Arkansas, Fayetteville.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target
1
Study location

Study Summary

One in every three children ages 2-19 years is overweight or obese. Although multifactorial in nature, obesity is primarily attributed to a mismatch between energy intake and energy expenditure (EE). Daily EE (DEE) can be partitioned between resting metabolic rate (RMR), EE associated with physical activity, and the thermic effect of food (TEF). RMR corresponds to the energy needed to sustain the body functions at rest and is also related to body composition (i.e., ratio of skeletal muscle mass to fat mass). Skeletal muscle mass is a large contributor to RMR; the more skeletal muscle mass, the higher the RMR (i.e., more energy expended at rest). In addition, muscle plays a central role in whole body protein metabolism and disrupted muscle metabolism is associated with the development of many common chronic diseases associated with obesity such as type 2 diabetes and cardiovascular disease. Although the contribution of disrupted muscle metabolism to chronic disease is well-established in older adults, the potential impact in children is unknown. The overall objective for this primary project application is to determine the role of breakfast protein consumption in improving energy metabolism, energy balance and skeletal muscle health in obese, school-aged children.

Primary Outcome

WBEE will be measured using doubly labeled water.

Interventions

  • OTHER Protein
  • OTHER Carbohydrate

Study Locations (1)

Arkansas

  • University of Arkansas - Fayetteville

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2018-06-21
Est. Completion 2020-08-31
Phase NA

What the finished NCT03602144 record still lists

NCT03602144 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 3,205-participant average among 22 other Nutrition trials with a reported enrollment target (97% lower).

The record links to 5 conditions, with Nutrition appearing as the primary indexed condition, and to 2 interventions - of which Protein is the first listed.

NCT03602144 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT03602144 about?

NCT03602144 is a clinical study titled "Breakfast and Muscle Health in Children". One in every three children ages 2-19 years is overweight or obese. Although multifactorial in nature, obesity is primarily attributed to a mismatch between energy intake and energy expenditure (EE). Daily EE (DEE) can be partitioned between resting metabolic rate (RMR), EE associated with physical ...

What is the current status of trial NCT03602144?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2018-06-21. Estimated completion is 2020-08-31.

What conditions does trial NCT03602144 study?

This clinical trial studies the following conditions: Nutrition, Body Composition, Body Weight Changes, Energy Expenditure, Muscle Mass.

What interventions are being tested in trial NCT03602144?

The interventions under investigation include: Protein (OTHER), Carbohydrate (OTHER).

Who is sponsoring clinical trial NCT03602144?

This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03602144 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nutrition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03602144's enrollment target sits among peer trials

88 14th of 22 higher than 9 of 22 other Nutrition trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Nutrition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03602144, the US trial registry maintained by the National Library of Medicine. NCT03602144 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.